← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Biovinc, Llc
Santa Barbara, CA
$10,069,192
Total funding
10
Grants
Funding over time
peak $2.4M · FY2015–25$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,069,192 · 10
By mechanism
R44$7,413,425 · 3
R42$1,500,000 · 1
R43$780,804 · 4
R41$374,963 · 2
Investigators at Biovinc, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Bone targeted delivery of an antimicrobial drug for osteomyelitis therapy$999,300
R44 · FY2020 · AI
A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures$992,575
R44 · FY2025 · AI
Bone targeted delivery of an antimicrobial drug for osteomyelitis therapy$988,634
R44 · FY2022 · AI
A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures$978,787
R44 · FY2024 · AI
Bone targeted delivery of an antimicrobial drug for osteomyelitis therapy$975,586
R44 · FY2021 · AI
Bone targeted antimicrobials for biofilm-mediated osteolytic infection treatment$750,000
R42 · FY2017 · DE
Bone targeted antimicrobials for biofilm-mediated osteolytic infection treatment$750,000
R42 · FY2018 · DE
Competitive Equilibrium-based Displacement of Bisphosphonates as Novel Therapeutic Approach for BRONJ$749,155
R44 · FY2018 · DE
Competitive Equilibrium-based Displacement of Bisphosphonates as Novel Therapeutic Approach for BRONJ$740,777
R44 · FY2017 · DE
Competitive Equilibrium-based Displacement of Bisphosphonates as Novel Therapeutic Approach for BRONJ$691,832
R44 · FY2018 · DE
A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures$296,779
R44 · FY2023 · AI
Bone Metastasis Specific 18F PET Imaging Probe for Breast Cancer$225,000
R41 · FY2019 · CA
Bone targeted antimicrobials for the treatment of diabetic foot related infections and osteomyelitis$225,000
R43 · FY2018 · AR
Novel Bisphosphonate 18F-PET and PET/optical Dual Modality Probes for Rheumatoid Arthritis Imaging$224,997
R43 · FY2015 · AR
Bone targeted delivery of an antimicrobial drug for osteomyelitis therapy$180,807
R43 · FY2016 · AI
Competitive Equilibrium-based Displacement of Bisphosphonates as Novel Therapeutic Approach for BRONJ$150,000
R43 · FY2015 · DE
Bone targeted antimicrobials for biofilm-mediated osteolytic infection treatment$149,963
R41 · FY2016 · DE